Advertisement
Solventum Corporation

Solventum Corporation (SOLV) Stock Overview

Explore Solventum Corporation’s financial performance, market position, analyst ratings, and future outlook.

SOLVNYSE
HealthcareMedical - Care Facilities
$75.96
$0.78(1.04%)
U.S. Market opens in 15h 21m
Advertisement

Solventum Corporation (SOLV)

Meyka AI Score

Z

Key Financials

Market Cap13.1B
P/E Ratio9.30
EPS (TTM)$6.24
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$72.54
3 Months$77.50
1 Year Target$81.94

SOLV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Solventum Corporation (SOLV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $81.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.30 and a market capitalization of 13.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.98%
5-Day Change
-2.97%
1-Month Change
-7.93%
3-Month Change
14.72%
6-Month Change
-11.86%
Year-to-Date (YTD) Change
-4.19%
1-Year Change
2.33%
3-Year Change
-5.10%
5-Year Change
-5.10%
All-Time (Max) Change
-5.10%

Contact Information

651-733-1110
3M Center, Maplewood, MN, 55144

Company Facts

220,000 Employees
IPO DateApr 1, 2024
CountryUS
Actively Trading

Frequently Asked Questions